tiprankstipranks
TELA Bio Reports Q3 2024 Preliminary Financial Results
Company Announcements

TELA Bio Reports Q3 2024 Preliminary Financial Results

Don't Miss our Black Friday Offers:

TELA Bio ( (TELA) ) just unveiled an announcement.

TELA Bio, Inc. has disclosed preliminary financial results for Q3 2024, showing an estimated revenue increase to $19.0 million from $15.1 million in the same period of 2023, with a gross margin slightly decreasing to 68%. The company ended the quarter with $17.3 million in cash, down from $46.7 million at the end of 2023. These results are unaudited and subject to revisions, urging investors to interpret the data cautiously.

See more insights into TELA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyTela Bio price target lowered to $5 from $8 at Piper Sandler
TipRanks Auto-Generated NewsdeskTELA Bio, Inc. Reports Record Revenue Growth
TheFlyTela Bio reports Q3 EPS (42c), consensus (40c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App